304 related articles for article (PubMed ID: 30652401)
1. Nested combination tests with a time-to-event endpoint using a short-term endpoint for design adaptations.
Jörgens S; Wassmer G; König F; Posch M
Pharm Stat; 2019 May; 18(3):329-350. PubMed ID: 30652401
[TBL] [Abstract][Full Text] [Related]
2. Statistical considerations for testing multiple endpoints in group sequential or adaptive clinical trials.
Hung HM; Wang SJ; O'Neill R
J Biopharm Stat; 2007; 17(6):1201-10. PubMed ID: 18027226
[TBL] [Abstract][Full Text] [Related]
3. Nonparametric adaptive enrichment designs using categorical surrogate data.
Brückner M; Burger HU; Brannath W
Stat Med; 2018 Dec; 37(29):4507-4524. PubMed ID: 30191578
[TBL] [Abstract][Full Text] [Related]
4. Testing multiple primary endpoints in clinical trials with sample size adaptation.
Liu Y; Hu M
Pharm Stat; 2016; 15(1):37-45. PubMed ID: 26607410
[TBL] [Abstract][Full Text] [Related]
5. Adaptive Designs with Discrete Test Statistics and Consideration of Overrunning.
Schmidt R; Burkhardt B; Faldum A
Methods Inf Med; 2015; 54(5):434-46. PubMed ID: 26429500
[TBL] [Abstract][Full Text] [Related]
6. Flexible stopping boundaries when changing primary endpoints after unblinded interim analyses.
Chen LM; Ibrahim JG; Chu H
J Biopharm Stat; 2014; 24(4):817-33. PubMed ID: 24697500
[TBL] [Abstract][Full Text] [Related]
7. Designing Issues in Confirmatory Adaptive Population Enrichment Trials.
Wassmer G; Dragalin V
J Biopharm Stat; 2015; 25(4):651-69. PubMed ID: 24905739
[TBL] [Abstract][Full Text] [Related]
8. Adaptive seamless designs with interim treatment selection: a case study in oncology.
Carreras M; Gutjahr G; Brannath W
Stat Med; 2015 Apr; 34(8):1317-33. PubMed ID: 25640198
[TBL] [Abstract][Full Text] [Related]
9. Optimal timing for interim analyses in clinical trials.
Togo K; Iwasaki M
J Biopharm Stat; 2013; 23(5):1067-80. PubMed ID: 23957516
[TBL] [Abstract][Full Text] [Related]
10. Evaluating futility of a binary clinical endpoint using early read-outs.
Van Lancker K; Vandebosch A; Vansteelandt S; De Ridder F
Stat Med; 2019 Dec; 38(28):5361-5375. PubMed ID: 31631357
[TBL] [Abstract][Full Text] [Related]
11. Analysis strategies for adaptive designs with multiple endpoints.
Chang M; Chow SC
J Biopharm Stat; 2007; 17(6):1189-200. PubMed ID: 18027225
[TBL] [Abstract][Full Text] [Related]
12. Adaptive clinical trial designs with blinded selection of binary composite endpoints and sample size reassessment.
Roig MB; Melis GG; Posch M; Koenig F
Biostatistics; 2023 Dec; 25(1):237-252. PubMed ID: 36150142
[TBL] [Abstract][Full Text] [Related]
13. An Adaptive Staggered Dose Design for a Normal Endpoint.
Wu J; Menon S; Chang M
J Biopharm Stat; 2015; 25(4):731-56. PubMed ID: 24904986
[TBL] [Abstract][Full Text] [Related]
14. Adaptive graph-based multiple testing procedures.
Klinglmueller F; Posch M; Koenig F
Pharm Stat; 2014; 13(6):345-56. PubMed ID: 25319733
[TBL] [Abstract][Full Text] [Related]
15. Design and analysis issues of multiregional clinical trials with different regional primary endpoints.
Tsou HH; Tsong Y; Chang WJ; Dong X; Hsiao CF
J Biopharm Stat; 2012 Sep; 22(5):1051-9. PubMed ID: 22946949
[TBL] [Abstract][Full Text] [Related]
16. A free gift: an adaptive strategy in a single-arm trial using an exact test through the binomial distribution.
Wang J
J Biopharm Stat; 2012; 22(6):1127-36. PubMed ID: 23075012
[TBL] [Abstract][Full Text] [Related]
17. Novel procedures for validating surrogate endpoints in clinical trials.
Cleophas TJ; Zwinderman AH; Chaib AH
Curr Clin Pharmacol; 2007 May; 2(2):123-8. PubMed ID: 18690859
[TBL] [Abstract][Full Text] [Related]
18. On sample size determination in multi-armed confirmatory adaptive designs.
Wassmer G
J Biopharm Stat; 2011 Jul; 21(4):802-17. PubMed ID: 21516570
[TBL] [Abstract][Full Text] [Related]
19. Patient recruitment strategies for adaptive enrichment designs with time-to-event endpoints.
Uozumi R; Yada S; Kawaguchi A
BMC Med Res Methodol; 2019 Jul; 19(1):159. PubMed ID: 31331277
[TBL] [Abstract][Full Text] [Related]
20. A Bayesian predictive sample size selection design for single-arm exploratory clinical trials.
Teramukai S; Daimon T; Zohar S
Stat Med; 2012 Dec; 31(30):4243-54. PubMed ID: 22807115
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]